)
)
PYC Therapeutics Investor Relations Material
Latest events
AGM 2024
PYC Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from PYC Therapeutics Limited
Access all reports
PYC Therapeutics Limited is an Australia-based biotechnology company focused on developing RNA-based therapies to treat genetic diseases. The company specializes in precision medicine, leveraging its RNA therapeutic platform to design and deliver drugs targeting the root causes of genetic disorders. PYC Therapeutics is involved in preclinical and clinical development, with a focus on rare inherited diseases, particularly those affecting vision and the central nervous system. The company is headquartered in Perth, Western Australia, and its shares are listed on the ASX.
Key slides for PYC Therapeutics Limited
AGM 2024
PYC Therapeutics Limited
Q2 2024 TU
PYC Therapeutics Limited
Latest articles
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
)
Lessons from Gautam Baid: Mastering Simplicity and Compounding
Gautam Baid's journey of compounding wisdom, investing simplicity, and lifelong learning – insights to transform your financial and personal growth.
13 Dec 2024
)
Rocket Lab: Breaking Ground in Space
Rocket Lab has been one of the pioneers in the commercial aerospace industry, with numerous satellite launches and space system applications.
9 Dec 2024
Ticker symbol
PYC
Country
🇦🇺 Australia